Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase I/II trial examines multiple doses of IL-4R in asthmatic patients

March 6, 2000

AAAAI news: icatibant effective in reducing antigen-induced nasal hyperresponsiveness in SAR

March 6, 2000

NicOx presents nitrate salts of respiratory medications with improved tolerance

March 6, 2000

EpiGenesis and Taisho sign binding letter of intent for EPI-2010

March 3, 2000

FDA approves new Allegra formulations

March 1, 2000

Zambon presents new PDE4 inhibitors useful for respiratory diseases

Feb. 29, 2000

Discovery to develop aerosolized formulations of Surfaxin

Feb. 28, 2000

New respiratory therapeutics from Zambon act as phosphodiesterase inhibitors

Feb. 28, 2000

PathoGenesis announces approval, distribution agreement for TOBI

Feb. 25, 2000

New treatment for COPD from Ono to enter clinical trials soon

Feb. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...